Literature DB >> 10532724

Visual prognosis of Coats' disease.

A S Budning1, E Heon, B L Gallie.   

Abstract

PURPOSE: Our purpose was to determine the visual prognosis of retinal telangiectasia (Coats' disease).
METHODS: We performed a retrospective review of 35 patients with Coats' disease seen at the Hospital for Sick Children, Toronto, Canada between 1987 and 1996. Ten patients were excluded because of incomplete records. Treatment modalities consisted of no treatment, cryotherapy with and without 532 nm laser through the indirect ophthalmoscope, and enucleation. Visual outcome was determined where possible.
RESULTS: Median follow-up was 4.5 years. Deterioration in visual acuity was associated with the presence of greater than 5 clock hours of involved retina and retinal detachment at diagnosis. Final visual acuity did not correlate with age of onset of disease. No eye treated with cryotherapy progressed to retinal detachment.
CONCLUSIONS: Aggressive treatment of Coats' disease with cryotherapy with or without 532 nm laser, before retinal detachment, is likely to stabilize vision and decrease the risk of future total retinal detachment.

Entities:  

Mesh:

Year:  1998        PMID: 10532724     DOI: 10.1016/s1091-8531(98)90034-9

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  8 in total

Review 1.  Ocular and systemic causes of retinopathy in patients without diabetes mellitus.

Authors:  Jayant Venkatramani; Paul Mitchell
Journal:  BMJ       Date:  2004-03-13

Review 2.  Paediatric retinal detachment: a review.

Authors:  Raffaele Nuzzi; Carlo Lavia; Roberta Spinetta
Journal:  Int J Ophthalmol       Date:  2017-10-18       Impact factor: 1.779

3.  Coats' disease: an Indian perspective.

Authors:  Pukhraj Rishi; Ekta Rishi; Mahesh Uparkar; Tarun Sharma; Lingam Gopal; Pramod Bhende; Muna Bhende; Pratik Ranjan Sen; Parveen Sen
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

4.  The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.

Authors:  Xiao-Xue Zheng; Yan-Rong Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-20       Impact factor: 3.117

5.  Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.

Authors:  Vishalakshi Bhat; Palmeera D'Souza; Parag K Shah; V Narendran
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Apr-Jun

6.  Coats' Disease: Very Long-Term Outcome After Early Stage Conventional Treatment.

Authors:  Salvatore Perrone; Alberto Rossetti; Patrick Sportiello; Pierfrancesco Mirabelli; Pierangela Cimatti; Daniele Doro
Journal:  Open Ophthalmol J       Date:  2016-02-29

7.  Bilateral Coats' Disease Combined with Retinopathy of Prematurity.

Authors:  Huseyin Gursoy; Nazmiye Erol; Mustafa Deger Bilgec; Hikmet Basmak; Ozden Kutlay; Huseyin Aslan
Journal:  Case Rep Ophthalmol Med       Date:  2015-08-30

8.  Coats' disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease.

Authors:  Yacoub A Yousef; Ahmad H ElRimawi; Rashed M Nazzal; Ahmad F Qaroot; Adnan H AlAref; Mona Mohammad; Omar Abureesh; Robert Rejdak; Katarzyna Nowomiejska; Teresio Avitabile; Mario Damiano Toro; Ibrahim AlNawaiseh
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.